Riskpilot← Back to searchSign inGet full accessGöteborgs Kvinnoklinik AB
ABActiveOrg 5567099600Odinsgatan 10General medical practice activities · NACE 8621Est. 20061-4 employees
Revenue 2024
SEK 11,4M
+6% vs 2023
EBITDA margin
22.4%
+67% vs 2023
Equity ratio
69.4%
Financial strength
Net profit 2024
SEK 2M
+56% vs 2023
| Revenue | SEK 11,4M | +6% |
| EBITDA | SEK 2,6M | +67% |
| Net profit | SEK 2M | +56% |
| Total assets | SEK 4,2M | -14% |
| Equity | SEK 2,9M | +1% |
| Employees | — | — |
Legal name
Göteborgs Kvinnoklinik AB
Org number
5567099600
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
30 augusti 2006
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva öppen sjuk- och hälsovård, förvaltning av fastigheter och värdepapper samt därmed förenlig verksamhet.
Address
Odinsgatan 10
Email
sven@gbgkk.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 13 760 | 13 131 | 12 042 | 10 776 | 11 377 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 4 015 | 2 846 | 1 779 | 1 533 | 2 553 |
| Depreciation & amort. | −111 | −18 | −18 | −18 | −18 |
| EBIT | 3 904 | 2 828 | 1 761 | 1 515 | 2 535 |
| Net financials | −4 | −4 | −249 | 114 | 34 |
| Profit before tax | 3 900 | 2 824 | 1 635 | 1 629 | 2 570 |
| Tax | −841 | −594 | −374 | −329 | −541 |
| Net profit | 3 059 | 2 230 | 1 261 | 1 300 | 2 029 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 388 | 6 964 | 4 766 | 4 826 | 4 167 |
| Equity | 4 421 | 4 451 | 3 562 | 2 862 | 2 892 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 967 | 2 512 | 1 204 | 1 964 | 1 276 |
| Total debt | 1 967 | 2 512 | 1 204 | 1 964 | 1 276 |
EBITDA margin
22.4%
This company
15.8%
Market median
+42% vs market
20202024
Equity ratio
69.4%
This company
38.2%
Market median
+82% vs market
20202024
Return on equity
70.2%
This company
18.4%
Market median
+282% vs market
20202024
Net profit margin
17.8%
This company
8.1%
Market median
+120% vs market
20202024
Asset turnover
2.73×
This company
1.12×
Market median
+144% vs market
20202024
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PH Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Svul 1 AB
Göteborgs Kvinnoklinik AB Board members of Göteborgs Kvinnoklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Håkan Aronsson | Audit | 0 companies |
| Sven Nielsen | Board of Directors | 0 companies |
| Ulf Zackrisson | Deputy Board Member | 0 companies |